Dear Colleagues,
It is with great pleasure that we invite you to the 3rd edition of our flagship academic meeting, Hematology Oncology Horoscope 3.0, to be held on 30th August 2026 at JW Marriott, Mumbai Sahar.
The landscape of Hematology-Oncology is evolving rapidly. Since our last meeting, we have witnessed major breakthroughs including rapid change in genetic and molecular risk stratification of hematological malignancies, the emergence of Menin and IDH1 inhibitors in AML, the Bispecific antibody revolution in Multiple Myeloma and Lymphoma, Immunotherapies in ALL and significant updates in MDS classifications.
Today, the clinical question has shifted from “What is the mutation?” to “How do we sequence therapies based on the mutation for the patient sitting in front of us?”
Why Attend?
- The “Horoscope” Perspective: Learn how to predict patient’s personalised treatments and outcomes using the latest biomarkers including cytogenetics and molecular studies, MRD, and clonal evolution patterns.
- Decipher the Data: We distil thousands of key abstracts from ASH 2025, EHA 2026, and other major publications from the past year into practical, concise clinical updates.
- Clinical Applicability: Our hallmark “How I Treat” sessions focus on translating cutting-edge molecular science into real-world clinical decision-making.
Join us for a highly interactive academic forum where science meets clinical practice, and together we chart the future of Hematology-Oncology care.
We look forward to welcoming you to Mumbai.
Sincerely,
Organizing Committee
Patron
Dr. Tarang Gianchandani
Group CEO – Healthcare Initiatives,
Chief Executive Officer,
Sir H. N. Reliance Foundation Hospital,
Mumbai
Organizing Committee
Dr. Balkrishna Padate
Director and Co-Lead Cellular Therapies,
Head Hematology Hemato-Oncology BMT & CART,
Sir H N Reliance Foundation Hospital and Research Centre, Girgaon, Mumbai
Dr. Manju Sengar
Senior Oncohematologist
Tata Memorial Center, Parel Mumbai
Dr. Joydeep Chakrabartty
Senior Consultant – Hematology Hemato Oncology & Clinical Lead – BMT Programme Consultant Haematologist and BMT physician
Narayana Hospitals, Kolkata
Dr. Nitin Sood
Hemato Oncologist & BMT Specialist
Director – Hemato Oncology & BMT
Medanta-The Medicity Gurugram
Dr. Anil Aribandi
Senior Consultant & Head
Haemato-Oncology & BMT
Sindhu Hospitals Hyderabad
Dr. Nazreen Desai
Associate Consultant Hematology,
Hemato-Oncology BMT & Cart
Sir HN Reliance Foundation Hospital Mumbai
Scientific Program
| Time | Topic |
|---|---|
| 08:00 AM Onwards | Registration |
| Master of Ceremony | Dr. Archi Arun Chawla, Mumbai; Dr. Almas Dalvi, Mumbai |
| 08:25 AM - 08:30 AM Speaker |
Welcome Note & Setting the Context Dr. Balkrishna Padate, Mumbai |
| Session Moderators | Dr. Suruchi Aggarwal, Bengaluru; Dr. Nakul Tikare, Goa |
| 08:30 AM - 10:20 AM | Session 1: |
| Chairpersons 08:30 AM - 08:50 AM Speaker |
Dr. Bipin Kulkarni, Mumbai; Dr. Shilpi Saxena, Mumbai Gold Standard molecular test for diagnosis and monitoring in hematology patients Dr. Mayur Parihar, Kolkata |
| Chairpersons 08:50 AM - 09:10 AM Speaker |
Dr. V A Arun, Mumbai; Dr. Nazreen Desai, Mumbai; Dr. Jay Juvekar, Mumbai Treatment decisions based on cytogenetics and molecular studies in AML patients Dr. Manju Sengar, Mumbai |
| Chairpersons 09:10 AM - 09:30 AM Speaker |
Dr. Pritam Kataria, Mumbai; Dr. Ritika Khurana, Mumbai; Dr. Shubhangi Agale, Mumbai Treatment decisions based on cytogenetics and molecular studies in ALL patients Dr. Balkrishna Padate, Mumbai |
| Experts 09:30 AM - 09:50 AM Speaker |
Dr. Naveed Tamboli, Mumbai ; Dr. Nishant Jindal, Mumbai Four Practice changing abstracts for EHA 2026 Dr. Ranjith Kumar C.S, Hyderabad |
| Chairpersons 09:50 AM - 10:20 AM Speaker |
Dr. Archana Swami, Mumbai; Dr. Juhi Shah, Mumbai; Dr. Amit Jain, Mumbai Pediatric Thrombocytopenia - Unmasking Inherited Disorders - A Case Based Discussion Dr. Mamta Manglani, Mumbai |
| Session Moderators | Dr. Sridhar Sivasubbu, Mumbai ; Dr. Renu Saxena, Delhi |
| 10:20 AM - 01:20 PM | Session 2: |
| 10:20 AM - 11:05 AM Moderator Panelists |
Panel Discussion - Indications for BMT & CAR-T in Hemato oncology patients - 3 cases Dr. Anusree Prabhakaran, Pune Dr. Digambar Panchal, Mumbai; Dr. Santanu Sen, Mumbai; Dr. Suraj Chiraniya, Mumbai; Dr. Maheboob Basade, Mumbai; Dr. Rajesh Patil, Mumbai ; Dr. Varun Bafna, Kolhapur; Dr. Aniket Mohite, Kolhapur; Dr. Nishant Jindal, Mumbai |
| Chairpersons 11:05 AM - 11:25 AM Speaker |
Dr. Darshit Shah, Mumbai; Dr. Kiran A Ghodke, Mumbai; Dr. Jeyhan B. Dhabhar, Mumbai Journey of Oncology patients in the last 10 years - Personalized treatment decision in oncology patients Dr. Sewanti Limaye, Mumbai |
| Chairpersons 11:25 AM - 11:45 AM Speaker |
Dr. Murlidharan C, Mumbai; Dr. Ashok Meshram, Kolkata Treatment decision based on cytogenetics & molecular studies in Multiple Myeloma Dr. Abhay Bhave, Mumbai |
| Chairpersons 11:45 AM - 12:05 PM Speaker |
Dr. Preeti Singh, Mumbai; Dr. Prochi Madon, Mumbai; Dr. Charu Bahl, Delhi Molecular Diagnostics in Hematology Dr. Abhay Uthale, Mumbai |
| 12:35 PM - 01:05 PM 12:05 PM - 12:35 PM Speaker |
Dr. Rajesh Patil, Mumbai; Dr. Pritam Kataria, Mumbai; Dr. Akash Bhojgaria, Kolkata Evolution of molecular studies and their impact on treatment of MDS, CML & non-CML MPN Dr. M B Agarwal, Mumbai |
| 12:35 PM - 01:05 PM Speaker |
TBA |
| 01:20 PM - 02:00 PM | LUNCH BREAK |
| Session Moderators | Dr. S H Advani, Mumbai; Dr. Pritesh Juanagade, Nashik; Dr. Shrinidhi Nathany, Gurugram ; Dr. Sweta Lunkad, Pune |
| 02:00 PM - 05:00 PM | Session 3: |
| Chairperson 02:00 PM - 02:20 PM Speaker |
Dr. Namita Padwal, Mumbai Treatment decision based on cytogenetics & molecular studies in Lymphoma Patients Dr. Sameer Tulpule, Mumbai |
| Chairperson 02:20 PM - 02:40 PM Speaker |
Dr. Varun Bafna, Kolhapur Maintenance therapy in Hemato-oncology patient based on cytogenetic & Molecular studies Dr. Joydeep Chakrabartty, Kolkata |
| Chairperson 02:40 PM - 03:00 PM Speaker |
Dr. Dipsha Kriplani, Mumbai; Dr. Darshana Rane, Mumbai; Dr. Jyoti Chirmade, Mumbai Treatment decision based on cytogenetics & Molecular studies in CLL patients Dr. Nitin Sood, Gurugram |
| Chairperson 03:00 PM - 03:15 PM Speaker |
TBA Servier Session TBA |
| Chairperson 03:15 PM - 03:35 PM Speaker |
Venclexta Voyage Transforming the treatment paradigm in CLL Dr. Sameer Tulpule, Mumbai |
| Chairperson 03:35 PM - 03:50 PM Speaker |
Dr. Aniket Mohite, Kolhapur ImmunoAct Session |
| Chairperson 03:50 PM - 04:05 PM Speaker |
Letermovir: life changing intervention in BMT patients Dr. Reetu Jain, Mumbai |
| Chairperson 04:05 PM - 04:25 PM Speaker |
Ethical, Legal and Social Issues with Whole Genome Sequencing in Today's Times Dr. Sachin Chaurasia, Mumbai |
| Chairperson 04:25 PM - 04:45 PM Speaker |
Dr. Vidisha Mahajan, Mumbai; Dr. Chitra Madiwale, Mumbai The role of the morphologist in the era of molecular diagnostics Dr. Archana Vazifdar, Mumbai |
| Chairperson 04:45PM - 05:00 PM Speaker |
Dr. Ashutosh Walawalkar, Mumbai; Dr. Nisha Iyer, Mumbai; Dr. Parth Ganatra, Mumbai; Dr. Nidhi Dhariwal, Mumbai Genetic diagnosis and clinical relevance in IBMFS Dr. Vipin Khandelwal, Mumbai |
| Vote of Thanks & Closing Remarks | |
Conference Registration
| Category | Early Bird Upto (31st July 2026) | Regular Rate Upto (15th August 2026) | Spot Rate From (16th August 2026) |
|---|---|---|---|
| Registration Fee Students (PG/UG/SR/JR/Researcher) |
INR 1500/- | INR 2500/- | INR 3500/- |
Notes:
- You will receive a registration confirmation email after the completed payment process at your registered email address within 24 hours with the Registration ID (Working days). Kindly check your Spam/Junk Mail in case you do not receive the confirmation in your inbox or contact Mr. Narayan Sharma on 9377724324.
- Registration is mandatory for all participants.
- The registration fee includes entry to all scientific sessions, Conference meals and delegate kit. Spot registrations are not guaranteed of conference kit.
- Employees of non-participating Pharma/diagnostics companies/market survey companies/ Hospital groups are not permitted to register/ enter conference venue.
- Event organizers, conference organizers, advertising agencies, and vendors are not permitted to register or enter the conference venue during the conference period.
- Students must submit a Bonafide Certificate from their head of Department/Institute during the abstract submission.
Cancellation Policy:
- Registrations cancelled 4 weeks befor ae the conference will be eligible for 75% refund of fees excluding GST (18%).
- After 15th August 2026, no refund requests will be accepted.
- Refund will be processed two weeks after the conference date.
Venue : JW Marriott, Mumbai Sahar
